Maternal Fatigue after Postpartum Anemia Treatment with Intravenous Ferric Carboxymaltose vs. Intravenous Ferric Derisomaltose vs. Oral Ferrous Sulphate: A Randomized Controlled Trial
(1) <b>Background:</b> Postpartum anemia is a common maternal complication and is recognized as a cause of impaired quality of life, reduced cognitive abilities, and fatigue. Efficient iron supplementation for the treatment of postpartum anemia is an essential component of high-quality m...
Main Authors: | Lea Bombač Tavčar, Hana Hrobat, Lea Gornik, Irena Preložnik Zupan, Marijana Vidmar Šimic, Polona Pečlin, Gorazd Kavšek, Miha Lučovnik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/3/758 |
Similar Items
-
Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial
by: Lea Bombač Tavčar, et al.
Published: (2023-12-01) -
Comparison of the use of intravenous iron sucrose with intravenous ferric Carboxymaltose for treatment of iron deficiency anaemia in pregnant patients
by: Khar un-Nisa, et al.
Published: (2022-11-01) -
Does Repeated Dosing of Intravenous Ferric Carboxymaltose Alleviate Symptoms of Restless Legs Syndrome?
by: Hea Ree Park, et al.
Published: (2022-03-01) -
Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study
by: Alberto Rosati, et al.
Published: (2022-09-01) -
Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction
by: Raquel López‐Vilella, et al.
Published: (2022-02-01)